Biologics by McKesson Revenue and Competitors

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • Biologics by McKesson's estimated annual revenue is currently $70.4M per year.(i)
  • Biologics by McKesson's estimated revenue per employee is $297,000

Employee Data

  • Biologics by McKesson has 237 Employees.(i)
  • Biologics by McKesson grew their employee count by 8% last year.

Biologics by McKesson's People

NameTitleEmail/Phone
1
VP, Provider SalesReveal Email/Phone
2
Sr Director Specialty Pharmacy OperationsReveal Email/Phone
3
Director, Business Development, Oncology and Rare DiseaseReveal Email/Phone
4
Sr Director Business IntelligenceReveal Email/Phone
5
Sr. Director Payor AccessReveal Email/Phone
6
Director - Strategic AccountsReveal Email/Phone
7
Director Quality MangementReveal Email/Phone
8
Sr Manager, Business Process OperationsReveal Email/Phone
9
Program ManagerReveal Email/Phone
10
Sr. Manager, PricingReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$76.6M2580%N/AN/A
#2
$109.4M324-1%N/AN/A
#3
$7.8M36-3%N/AN/A
#4
$14.3M59-3%N/AN/A
#5
$27.3M10117%N/AN/A
#6
$17M70-7%N/AN/A
#7
$1.6M10-68%N/AN/A
#8
$421.5M1115N/AN/AN/A
#9
$29.7M110-21%N/AN/A
#10
$58.2M1968%N/AN/A
Add Company

What Is Biologics by McKesson?

Biologics by McKesson is an independent specialty pharmacy. We are committed to connecting patients to life-changing medications in oncology and other complex therapeutic areas. We simplify access to therapies and deliver personalized care that helps patients achieve the best-possible outcomes. At Biologics by McKesson, our mission is to simplify access to medication and deliver personalized care that helps patients achieve the best-possible outcomes ? one patient, one partner, one therapy at time. Built on the foundation of deep clinical expertise and a white-glove approach to patient care, Biologics delivers both our patients and our partners with seamless access to therapies and unmatched personalized engagement, so our patients get the most out of the care they receive. With access to over 60 limited distribution contracts, including approximately 10 exclusive therapies, Biologics has become a leader in the specialty pharmacy space by taking exceptional care of patients and leveraging established, collaborative relationships with clinicians, payers and biopharma companies to align patient care across the healthcare continuum. At Biologics, we are nurses, pharmacists, patients, caregivers, community leaders, Fortune #7 employees, innovators, partners, collaborators, thought Leaders, analysts, coaches, and experts. And we all find our ?Why? ? our purpose, our cause and our belief ? in our patients.

keywords:N/A

N/A

Total Funding

237

Number of Employees

$70.4M

Revenue (est)

8%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Biologics by McKesson News

2022-04-17 - CAH: 4 Medical Distributor Stocks That Deserve a Place in ...

... selected MCK's Biologics by McKesson, an independent specialty pharmacy specializing in oncology and rare diseases, as a specialty...

2022-04-17 - CAH: 4 Medical Distributor Stocks That Deserve a Place in ...

... selected MCK's Biologics by McKesson, an independent specialty pharmacy specializing in oncology and rare diseases, as a specialty...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$39.6M240N/AN/A
#2
$39.9M25041%N/A
#3
$35M2518%N/A
#4
$40.7M26443%N/A
#5
$76.9M2651%N/A